Sangair AB
559080-3317ActiveDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Biotechnology Companysangair.se
Oversigt
- 5–9
- Medarbejdere
- 1–49t SEK
- Omsætning
- 2016
- Grundlagt
Nøglebeslutningstagere
Susanne Olausson
Board member
Johan Sjöholm
Board Member, Founder
Henrik Rundgren
Board member
Martin Wiklund
Board member
+2 flere kontakter i Funnelfeedr
Beskrivelse
Sangair AB is a Swedish biotechnology company focused on developing innovative solutions for critical medical conditions. Their core innovation is SangAsept, a unique process designed to treat blood extracorporeally, meaning outside the body. This technology immediately targets and reduces harmful b...